Pieris Pharmaceuticals, Inc. (PIRS)
USD 13.6
(-15.58%)
USD 13.6
(-15.58%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -53.81 Million | -59.93 Million | -7.66 Million | -45.89 Million | -52.46 Million | -1.06 Million |
| Net Income | -24.54 Million | -33.27 Million | -45.73 Million | -37.23 Million | -25.46 Million | -26.75 Million |
| Depreciation & Amortization | 1.9 Million | 2.78 Million | 2.36 Million | 2.12 Million | 1.04 Million | 570 Thousand |
| Deferred income taxes | -4.51 Million | - | - | 164 Thousand | -1.22 Million | -164 Thousand |
| Stock-based compensation | 3.34 Million | 4.4 Million | 5.21 Million | 5.09 Million | 5.37 Million | 4.94 Million |
| Change in working capital | -7.38 Million | -33.37 Million | 30.52 Million | -16.37 Million | -32.12 Million | 21.89 Million |
| Other non-cash items | -27.14 Million | -467 Thousand | -30 Thousand | 330 Thousand | -69 Thousand | -1.55 Million |
| Investing Cash Flow | 12 Million | -21.23 Million | -949 Thousand | 39.21 Million | 9.83 Million | -8.87 Million |
| Investments in PPE | -171 Thousand | -1.04 Million | -949 Thousand | -2.72 Million | -2.46 Million | -1.69 Million |
| Acquisitions | -12.17 Million | 20.19 Million | - | -41.93 Million | -12.3 Million | - |
| Investment purchases | -22.83 Million | -48.39 Million | - | -41.49 Million | -59.31 Million | -117.58 Million |
| Sales/Maturities of investments | 35 Million | 28.2 Million | - | 83.43 Million | 71.61 Million | 110.4 Million |
| Other Investing Activities | 12.17 Million | -20.19 Million | - | 41.93 Million | 12.3 Million | -7.17 Million |
| Financing Cash Flow | 19.79 Million | 7.21 Million | 59.12 Million | 10.11 Million | 32.16 Million | 48.51 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 19.79 Million | 7.21 Million | 57.1 Million | 9.62 Million | 30.99 Million | 47.21 Million |
| Other Financing Activities | 19.79 Million | 7.21 Million | 2.02 Million | 491 Thousand | 1.16 Million | 1.3 Million |
| Accounts receivables | 5.3 Million | -2.62 Million | -1.81 Million | 5.34 Million | -4.05 Million | 12.51 Million |
| Accounts payables | -789 Thousand | -4.2 Million | 7.04 Million | -4.35 Million | 1.25 Million | 764 Thousand |
| Inventory | - | - | 5.73 Million | -2.87 Million | -799 Thousand | - |
| Other working capital | -12.69 Million | -26.53 Million | 19.55 Million | -14.49 Million | -28.52 Million | 8.61 Million |
| Cash at beginning of period | 38.63 Million | 117.76 Million | 70.43 Million | 62.26 Million | 74.86 Million | 37.87 Million |
| Cash at end of period | 17.39 Million | 38.63 Million | 117.76 Million | 70.43 Million | 62.26 Million | 74.86 Million |
| Capital Expenditure | -171 Thousand | -1.04 Million | -949 Thousand | -2.72 Million | -2.46 Million | -1.69 Million |
| Effect of forex changes on cash | 783 Thousand | -5.17 Million | -3.19 Million | 4.74 Million | -2.14 Million | -1.58 Million |
| Net cash flow / Change in cash | -21.23 Million | -79.12 Million | 47.32 Million | 8.17 Million | -12.6 Million | 36.98 Million |
| Free Cash Flow | -53.99 Million | -60.97 Million | -8.6 Million | -48.62 Million | -54.92 Million | -2.76 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -3.59 Million | -4.89 Million | -4.58 Million | -24.54 Million | -10.75 Million | 3.97 Million |
| Depreciation & Amortization | - | -30 Thousand | -198 Thousand | 1.78 Million | 708 Thousand | 725 Thousand |
| Deferred income taxes | - | - | -253 Thousand | -4.51 Million | 14.89 Million | -106 Thousand |
| Stock-based compensation | 421 Thousand | 472 Thousand | 451 Thousand | 3.34 Million | 966 Thousand | 1.04 Million |
| Change in working capital | 2.19 Million | -3.96 Million | -14.33 Million | -48.14 Million | -15.51 Million | -18.89 Million |
| Other non-cash items | -82 Thousand | 1.82 Million | -748 Thousand | 16.12 Million | -19 Thousand | -182 Thousand |
| Investing Cash Flow | 2.17 Million | 9 Million | 3.44 Million | 12 Million | -1.98 Million | -1.36 Million |
| Investments in PPE | - | - | 13 Thousand | -171 Thousand | -69 Thousand | -67 Thousand |
| Acquisitions | - | - | -3.43 Million | -12.17 Million | 1.91 Million | 1.29 Million |
| Investment purchases | - | - | -7.56 Million | -22.83 Million | -7.02 Million | -6.69 Million |
| Sales/Maturities of investments | 2.17 Million | 9 Million | 11 Million | 35 Million | 5.11 Million | 5.4 Million |
| Other Investing Activities | 2.17 Million | 9 Million | 3.43 Million | 12.17 Million | -1.91 Million | -1.29 Million |
| Financing Cash Flow | - | - | 14 Thousand | 19.79 Million | - | 19.78 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 14 Thousand | 19.79 Million | - | 19.72 Million |
| Other Financing Activities | - | - | 14 Thousand | 19.79 Million | - | 52 Thousand |
| Accounts receivables | - | - | 5.3 Million | 5.3 Million | - | - |
| Accounts payables | - | - | -805 Thousand | -789 Thousand | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 2.74 Million | -3.4 Million | 21.11 Million | -52.65 Million | -15.51 Million | -18.89 Million |
| Cash at beginning of period | 19.08 Million | 17.39 Million | 32.89 Million | 38.63 Million | 44.93 Million | 39.74 Million |
| Cash at end of period | 19.73 Million | 19.08 Million | 17.39 Million | 17.39 Million | 32.89 Million | 44.93 Million |
| Capital Expenditure | - | - | 13 Thousand | -171 Thousand | -69 Thousand | -67 Thousand |
| Effect of forex changes on cash | -49 Thousand | -316 Thousand | 708 Thousand | 783 Thousand | -337 Thousand | 212 Thousand |
| Net cash flow / Change in cash | 647 Thousand | 1.68 Million | -15.49 Million | -21.23 Million | -12.04 Million | 5.19 Million |
| Free Cash Flow | -1.48 Million | -6.99 Million | -19.65 Million | -53.99 Million | -9.79 Million | -13.49 Million |
228670
GMPW
FFDF
JJFINCOR
ESHDF
CHNUF